DXP director granted 648 shares at $165.90
MANNES JOSEPH R reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
MANNES JOSEPH R reported acquisition or exercise transactions in this Form 4 filing.
DXP Enterprises Inc. director Joseph R. Mannes reported receiving a grant of 648 shares of DXP Common Stock, valued at $165.90 per share. After this award, he holds 14,612 shares directly. The grant is scheduled to fully vest one year from its July 1, 2026 grant date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | DXP Common Stock | 648 | $165.90 | $108K |
Footnotes (1)
- F1. The term of the grant provide for full vesting one year from the date of grant. [Grant date July 1, 2026 - 648 shares]
Key Figures
Key Terms
DXP Common Stock financial
Grant date financial
vesting financial
Grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did DXP Enterprises (DXPE) director Joseph R. Mannes report?
Was the DXP Enterprises (DXPE) transaction by Joseph R. Mannes a market buy or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.